Sarcoma, Clear Cell - 20 Studies Found
Not yet recruiting |
: QUILT-3.031: AMG 337 in Subjects With Advanced or Metastatic Clear Cell Sarcoma : Clear Cell Sarcoma : 2017-04-20 : Drug: AMG 337 6-{(1R)-1-[8-fluoro-6-(1-methyl-1H-pyrazol-4-yl)[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl}- |
Not yet recruiting |
: Chemotherapy Followed by Surgery and Radiation Therapy With or Without Stem Cell Transplant in Treating Patients With Relapsed or Refractory Wilms' Tumor or Clear Cell Sarcoma of the Kidney : Kidney Cancer : 2001-10-11 :
|
Active, not recruiting |
: Vaccine Trial for Clear Cell Sarcoma, Pediatric Renal Cell Carcinoma, Alveolar Soft Part Sarcoma and Children With Stage IV Melanoma :
: Biological: GVAX 4 vaccines every two weeks |
Completed |
: Phase 2 Study in Patients With MiT Tumors :
|
Recruiting |
: Induction Therapy With Vemurafenib and Cobimetinib to Optimize Nivolumab and Ipilimumab Therapy : Melanoma, Malignant, of Soft Parts : 2016-11-11 : Drug: Vemurafenib and Cobimetinib Combination of Vemurafenib with Cobimetinib in BRAF V600E/K mutated me |
Completed |
: Biomarkers in Tissue Samples From Patients With High-Risk Wilms Tumor :
|
Completed |
: Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery :
|
Recruiting |
: CREATE: Cross-tumoral Phase 2 With Crizotinib :
|
Not yet recruiting |
: Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors :
|